Company
Estrigenix Therapeutics
Pioneering therapies to improve women’s health
Also known as Estrigenix, Estrigenix Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Milwaukee, Wisconsin, United States
- Founded
- 2018
- Customers
- interested pharmaceutical companies
- Legal name
- Estrigenix Therapeutics, Inc.
- estrigenix.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Estrigenix Therapeutics, Inc. was formed in 2018 to develop and commercialize first-in-class therapeutics to treat and prevent hot flashes and dementia in post-menopausal women.
Funding snapshot
- Total raised
- $2MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed, $2M2026-07-21
Funding rounds
- Seed
- $2M2026-07-21, Company stated
- Round, 2026
- $1M2026-07-17, SEC form D sold, 1 investor
Loading relationship preview